Population-based incidence of gastrointestinal stromal tumors in Puglia.

Tumori

Cancer Registry of the Local Health Unit of Barletta-Andria-Trani, section of the Puglia Cancer Registry, Barletta, Italy.

Published: February 2021

Introduction: This study presents the incidence of gastrointestinal stromal tumors (GISTs) in an Italian region of over 4 million inhabitants monitored for 10 years and is the largest incidence study of this type of cancer conducted so far in Italy.

Methods: In order to ensure the registration of all GISTs, including those with nonmalignant behavior, a cancer list was integrated with the cases found through an ad hoc data mining process that covered all the pathologic reports of Puglia. Case distributions by sex, age groups, site, and prognostic groups according to Miettinem and Lasota classification and crude and age-standardized incidence rates were produced.

Results: In the 10-year period 2006 to 2015, 708 cases of GIST were recorded in Puglia. The average crude incidence rate was 1.7 per 100,000 person-years and the age-standardized incidence rate, using 2013 European standard population, was 1.8 per 100,000 person-years (95% confidence interval [CI], 1.6-1.9). Incidence was higher in men than in women: crude incidence rate was 2.0 per 100,000 person-years and age-standardized incidence rate 2.2 per 100,000 person-years (95% CI, 2.0-2.4) in men and 1.5 per 100,000 person-years and 1.4 per 100,000 person-years (95% CI, 1.2-1.6) in women.

Discussion: Our incidence rates are comparable with those of other international studies and they are located in the medium to high end of the range. The comparisons are affected by a different capacity of the cancer registries to intercept and record GISTs with nonmalignant behavior. Distribution of cases for sex, age groups, sites, and prognostic risk groups are consistent with previous results.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0300891620931944DOI Listing

Publication Analysis

Top Keywords

100000 person-years
24
incidence rate
16
age-standardized incidence
12
rate 100000
12
person-years 95%
12
incidence
9
incidence gastrointestinal
8
gastrointestinal stromal
8
stromal tumors
8
nonmalignant behavior
8

Similar Publications

Purpose: To investigate the epidemiological trends and socioeconomic disparities associated with ankylosing spondylitis (AS) in South Korea over a decade (2010-2021) using National Health Insurance Service (NHIS) claims data.

Materials And Methods: Employing data from the NHIS database, this study identified 31753 incident AS patients in 2010-2021. We calculated the annual age-standardized prevalence and incidence rates and analyzed crude incidence rates and diagnostic patterns across age groups.

View Article and Find Full Text PDF

Pancreatic cancer risk after benign gallbladder disease: A Swedish population-based cohort study.

Eur J Cancer

January 2025

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden; General Practice Research Unit (AFE) and Department of General Practice, Institute of Health and Society, University of Oslo, Oslo, Norway; Vårdcentralen Värmlands Nysäter and Centre for Clinical Research, County Council of Värmland, Värmland, Sweden.

Article Synopsis
  • - The study aimed to investigate the risk of pancreatic cancer following benign gallbladder disease (GBD) in a nationwide cohort of Swedish individuals aged 20-79 who had undergone cholecystitis or cholecystectomy from 1992 to 2016, along with matched non-exposed individuals.
  • - Over a 15-year period, the researchers found that those with a history of GBD had a significantly higher incidence of pancreatic cancer within the first two years after diagnosis, with a hazard ratio of 2.74, particularly in younger patients aged 20-49, where the risk was even more pronounced.
  • - The results suggest the need for increased clinical monitoring for pancreatic cancer in patients who have
View Article and Find Full Text PDF

Background: The epidemiology and management of thyroid cancer has changed radically in the recent past, with rising international incidence of early-stage papillary thyroid cancer (PTC) in particular. In this paper, we review the epidemiology of thyroid cancer in Ireland.

Methods: A retrospective cohort study of National Cancer Registry of Ireland data, 1994-2019.

View Article and Find Full Text PDF

Background: We aim to present incidence rates and geographical distribution of most common early-onset gastrointestinal cancers (EOGICs), including early-onset esophageal cancer (EOEC), gastric cancer (EOGC) and colorectal cancer (EOCRC) in Iran, 2014-2018.

Methods: Data on new cases of EOEC, EOGC and EOCRC were obtained from publicly available annual reports of the Iranian National Population-based Cancer Registry (INPCR). Incidence rates were calculated using the population data available from the Statistical center of Iran.

View Article and Find Full Text PDF

[Analysis of disease burden of lung cancer attributable to chromium in Chinese population from 1990 to 2019].

Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi

November 2023

Institute of Occupational Disease Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210028, China.

Article Synopsis
  • The study analyzes the disease burden and trends of lung cancer due to chromium exposure in China from 1990 to 2019, focusing on its implications for health policy and prevention strategies.
  • In 2019, lung cancer cases attributable to chromium were significantly higher compared to 1990, with increases in incidence (224.1%), deaths (185.2%), and disability-adjusted life years (156.3%), surpassing global averages.
  • The standardized rates for morbidity, mortality, and DALYs in 2019 were also substantially higher than in 1990, indicating a growing public health concern, particularly affecting males more than females.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!